Second ZPMU retreat

On 25 July, the ZPMU invited members of the ZPMU Executive Board, experts from the various specialist disciplines involved in the Molecular and Familial Tumour Board and the Molecular Inflammation Board, representatives of patient organisations and regional partners to the regular ZPMU retreat.
Following presentations on the Centre's current activities and progress, the participants worked together in a "World Café" with themed tables on the following topics
- Towards the future: How AI can support us in a meaningful way
- Strengthening partners - Increasing reach:
Shaping successful outreach together
- Involving patient representatives - but how?
Strategies for active participation
- Inflammation medicine between expectations and resources
Concepts for strengthening interdisciplinary collaboration and regional networking and defining suitable measures for the future direction and further development of the centre.


   

  

    

    

   

Information event for patients with oncological diseases, their relatives and interested parties

On Thursday, 17 July, the experts from the Centre for Personalised Medicine Ulm (ZPMU) invited patients, relatives and interested parties to an information day at Ulm University Hospital (UKU).
Prof. Dr Thomas Seufferlein, Medical Director of the Department of Internal Medicine I at the UKU and spokesperson for the centre, opened the event with a brief presentation of the care offered by the ZPM Ulm. In addition, Prof. Dr Katja Lotz, DHBW Heilbronn, gave a guest lecture on the possibilities and limitations of personalised nutrition concepts in cancer therapy.
Patient catering in oncology clinics was one of the topics discussed with lively participation from the audience. It was discussed that the provision of meals to patients is often decoupled from the area of responsibility of the individual clinics for economic reasons and at the same time it was stated that more importance must be attached to personalised nutritional concepts as a supporting component of therapy. The current state of scientific knowledge on personalised nutrition was also reported on.
Afterwards, the visitors were divided into two parallel workshops. PD Dr Rebecca Kassubek provided information on modern diagnostic and therapeutic concepts in neuro-oncology and Prof. Dr Dr Sabine Heublein on new examination and treatment options in oncological gynaecology.
The event ended with a visit to the exhibitors' stands, a varied snack and interesting discussions.

     

    

    

Informationsveranstaltung für Ärzte aller Fachrichtungen

Immuntherapien bei chronisch-entzündlichen Erkrankungen Alles über Biologika und small-molecules

Das Zentrum für Personalisierte Medizin Ulm (ZPMU) - Bereich Immunvermittelte Erkrankungen (ZPMi) hat am 27. November 2024 zu einer Informationsveranstaltung für Ärzte aller Fachrichtungen in den Donausaal eingeladen. Bereits ab 16:30 Uhr öffnete die Ausstellung im Foyer und Partner aus der Industrie informierten über Ihre Angebote. 
Prof. Dr. Thomas Seufferlein, Sprecher des ZPMU, begrüßte die zahlreichen Besucher und PD Dr. Jochen Klaus, ZPMi-Sprecher, gab eine Kurzvorstellung des ZPMi. Anschließend führten PD Dr. Jochen Klaus und Ernst Waldner (niedergelassener Hausarzt aus Ulm) in die Thematik der Immuntherapien bei chronisch-entzündlichen Erkrankungen ein.
Im weiteren Verlauf des Abends gab es detaillierte Informationen zu Biologika und small molecules und Vorträge von den Fachärzten des Universitätsklinikums zur Therapieauswahl in Dermatologie, Gastroenterologie, Rheumatologie sowie Pädiatrie.
Abschließend referierte Dr. Michael Viapiano von der Kassenärztlichen Vereinigung Baden-Württemberg über die Verordnung von Biologika und small molecules durch Nicht-Spezialisten bevor der Abend bei fachlichem Austausch und einem Imbiss im benachbarten Restaurant „Treibgut“ seinen Ausklang fand.

   

   

   

Informationsveranstaltung für Patienten mit onkologischen Erkrankungen und deren Angehörige

Personalisierte Medizin und Künstliche Intelligenz – was bedeutet das für mich als Patient?

Das Zentrum für Personalisierte Medizin am Universitätsklinikum Ulm (ZPMU) hat am Montag, 25.11.24 von 17:00 – ca. 19:30 Uhr zu einer Informationsveranstaltung eingeladen.
Die Veranstaltung hat mit einem sehr spannenden Gastvortrag von Prof. Dr. med. Dr. phil. Torsten Haferlach, MLL Münchner Leukämielabor, begonnen. Er beleuchtete die Potentiale der Künstlichen Intelligenz in der Medizin.
Ein weiterer wesentlicher Aspekt der Veranstaltung lag in der Darstellung des Versorgungsangebots des ZPMU. Unter Beteiligung des Patientenbeirats des Comprehensive Cancer Centers Ulm soll die Personalisierte Medizin insbesondere auch aus dem Blickwinkel der Patienten betrachtet werden. Weiterhin haben Fachexperten des Standorts über moderne Diagnostik- und Therapiekonzepte bei Sarkomen und Hals-Nasen-Ohren-Tumoren als auch über personalisierte Sportkonzepte bei Krebs informiert. Die Veranstaltung endete dann mit einer Expertendiskussion samt Fragerunde.

.

    

   

   

   

Information event for patients with immune-mediated diseases

The Centre for Personalised Medicine Ulm (ZPMU) - Division of Immune-Mediated Diseases (ZPMi) hosted a free information event for patients with chronic inflammatory diseases on 25 September 2024. The information and hands-on stands with practical tips on nutrition, skin care and relaxation techniques opened at 4.30 pm. At the same time, partners from the industry provided information about their offers for patients.
Afterwards, PD Dr Jochen Klaus, spokesperson for the ZPMi, welcomed the visitors and provided information about the care offered by the ZPMi.
Based on the realisation that chronic inflammatory diseases are often immunologically and also genetically related, dermatologists, gastroenterologists and rheumatologists have joined forces at the ZPMi at Ulm University Hospital to improve the long-term suffering of patients with immune disorders with a new interdisciplinary treatment approach.
The centre therefore offers an interdisciplinary consultation option for patients with immune-mediated diseases such as psoriasis, associated rheumatism or chronic inflammatory bowel disease.
After a short snack, four workshops started, which enabled patients to obtain even more specific information and ask specific questions.

 

Information day for patients with oncological diseases and their relatives

Prof. Dr Thomas Seufferlein, Centre Spokesperson, and PD Dr Verena Gaidzik, Deputy Centre Spokesperson and Head of the Molecular and Familial Tumour Board (MoFa), hosted a free information day for cancer patients, their relatives and interested parties on 8 July 2023. The event provided information about personalised medicine in the field of oncology. The processes at MoFa were illustrated using case studies. The individual expert workshops provided in-depth insights into the possibilities of new imaging techniques and personalised diagnostic and therapeutic approaches for urological and neurological tumours. The focus of the event was on patients, their needs, expectations and hopes with regard to personalised medicine.

First ZPMU retreat at the Science Centre of the University of Ulm Schloss Reisensburg

"Where do we stand - where do we want to go?" was the motto of the first ZPMU retreat. Around 35 guests accepted Prof. Seufferlein's invitation to attend lectures, discussions and talks on 26 June 2023 in glorious weather and a charming setting at Reisensburg Castle.
Guests from the ZPMU Board of Directors, the various specialist disciplines involved in the Molecular and Familial Tumour Board and the ZPM team as well as members of patient organisations and regional partners were invited.
The aim of the event was to talk about current activities and progress at the ZPMU and to discuss needs with the involvement of all participants. Suitable measures for the future direction and further development of the centre could be determined from the joint exchange.

 

 

 

Information day for patients with chronic inflammatory diseases

On 18 March 2023, patients, doctors and patient and pharmaceutical representatives came together at Ulm University Hospital. The Centre for Personalised Medicine (ZPM), under the medical direction of Prof. Dr Thomas Seufferlein (spokesperson for the centre) and PD Dr Jochen Klaus (spokesperson for the Inflammation department), invited patients and their relatives to a free information day, as the ZPM network is now opening up to people with chronic inflammatory diseases.
The event provided information about the care offered by the ZPM Ulm. The centre offers an interdisciplinary consultation service for patients with chronic inflammatory bowel disease, psoriasis or psoriatic arthritis/spondyloarthritis. The aim of the ZPM is to find the best possible therapy option, individually tailored to the clinical picture, for successful and long-term control of the stressful symptoms.